Innovation Pharmaceuticals Inc
OTC:IPIX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innovation Pharmaceuticals Inc
OTC:IPIX
|
US |
|
Almirall SA
MAD:ALM
|
ES |
|
V
|
VICI Properties Inc
F:1KN
|
US |
|
Aerkomm Inc
OTC:AKOM
|
US |
|
D
|
Domiki Kritis SA
F:F9P
|
GR |
|
H
|
Huddly AS
OSE:HDLY
|
NO |
|
A
|
Avalon Globocare Corp
NASDAQ:ALBT
|
US |
|
V
|
Visteon Corp
XMUN:VS51
|
US |
|
L
|
Lattice Semiconductor Corp
XMUN:LTT
|
US |
|
United Renewable Energy Co Ltd
TWSE:3576
|
TW |
|
Austal Ltd
ASX:ASB
|
AU |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
P
|
PHC Co Ltd (Seongnam)
KOSDAQ:057880
|
KR |
|
H
|
Helix Resources Ltd
ASX:HLX
|
AU |
|
H
|
Healius Ltd
SWB:PGZ
|
AU |
|
H
|
Hainan Manaslu Acquisition Corp
NASDAQ:ABLV
|
CN |
|
L
|
Lion Energy Ltd
ASX:LIO
|
AU |
|
Karin Technology Holdings Ltd
SGX:K29
|
HK |
Bankruptcy Probability
Innovation Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Innovation Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Innovation Pharmaceuticals Inc
OTC:IPIX
|
155.5k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
453.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
236.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
187.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
138.4B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
85.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.4B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
83.6B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Innovation Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Innovation Pharmaceuticals Inc has total debt of 695k USD. This includes both short-term (238k USD) and long-term (457k USD) debt.
You can find a full breakdown on its Balance Sheet.
